To address the treatment effect of T-96 in vitiligo we constructed our mouse model as described in Methods and summarized in Fig. 1A, which relied on endogenous auto-reactive CD8+ cell targeting melanocytes achieved through transient inoculation of B16F10 melanoma cells and depletion of CD4+ regulatory T cells. The gene discussed is CD8A; the disease is vitiligo.